• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOLTA MEDICAL, INC THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES; ELECTROSURGICAL,CUTTING & COAGULATION & ACC.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOLTA MEDICAL, INC THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES; ELECTROSURGICAL,CUTTING & COAGULATION & ACC. Back to Search Results
Model Number TT4.00F6-900
Device Problem Excessive Heating (4030)
Patient Problems Partial thickness (Second Degree) Burn (2694); Blister (4537)
Event Date 09/29/2022
Event Type  Injury  
Manufacturer Narrative
The product has been requested and the investigation is underway.
 
Event Description
A user facility reported burns (2nd degree blisters) to the patient's left cheek during a thermage flx treatment to the face.The patient was treated with biomycin ointment.The current status was reported as blisters that are recovering with the possibility of a scar.Available pictures were reviewed by the medical reviewer and inflammation and erythema with minor blisters on lower left side of the face are visible.The patient was administered an iv superficial anesthetic for this procedure.It is reported that the blisters are resolving.No other treatments (besides thermage) were being performed in the same area where symptoms were reported.The patient has not undergone any other treatments in the same symptom area within the past 30 days.The incident occurred at about 72 reps.The highest energy level used was tl 4.A "tip too warm" error occurred during treatment.The tip was switched to another one and no issues were reported.Solta medical cryogen and coupling fluid were used during this treatment.Approximately 40-60 ml of coupling fluid was used during the treatment.The treatment tip surface was inspected prior to use and nothing remarkable was anything noted.This is the first time the treatment tip was used.
 
Manufacturer Narrative
The datalogs were reviewed and based on the evaluation of the data, the handpiece and system performed as expected.The system has software safeguards (such as a power on self-test) that will trigger error/event codes should the system be outside of acceptable limits.The tip was evaluated, and the tip failed the leak test.The tip also failed visual inspection for disturbed glue in one corner.No dielectric breakdown was observed.The datalogs also showed that the tip had an issue with the cryogen distribution.The thermistor 1 appeared warmer than the other thermistors; however, the tip passed the thermistor test.No functional testing was performed due to the tip being expired.It was reported that the patient was given iv superficial anesthetic for the treatment.The patient should never be placed under anesthetics during thermage flx treatment.The patient must be alert and provide required feedback during treatment.Patient feedback regarding their perception of heat or discomfort during the procedure is an essential input to guide the operator in determining safe and effective treatment levels.Based on the available information, this treatment was performed in an off-label manner that resulted in unsafe conditions for the patient.A review of the manufacturing records showed all requirements were met.The complaint type is identified within the risk analysis.The lot history, trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.Final test verification specifications are acceptable.No non-conformities or anomalies found related to this complaint when reviewing the device history record.No corrective action is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES
Type of Device
ELECTROSURGICAL,CUTTING & COAGULATION & ACC.
Manufacturer (Section D)
SOLTA MEDICAL, INC
11720 n creek pkwy n
ste 100
bothell WA 98011
Manufacturer (Section G)
SOLTA MEDICAL, INC.
11720 n creek pkwy n
ste 100
bothell WA 98011
Manufacturer Contact
sundeep jain
11720 n creek pkwy n
ste 100
bothell, WA 98011
4254202135
MDR Report Key15677104
MDR Text Key302472412
Report Number3011423170-2022-00138
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeTW
PMA/PMN Number
K170758
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTT4.00F6-900
Device Catalogue NumberTT4.00F6-900
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/26/2022
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received12/02/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/17/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-